Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000426345 | SCV000534895 | pathogenic | not provided | 2022-12-09 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27824329, 31981491, 33043365, 33004838) |
Diagnostic Laboratory, |
RCV001260712 | SCV001437804 | pathogenic | Intellectual disability | 2020-09-10 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV001823138 | SCV002073020 | pathogenic | Developmental and epileptic encephalopathy, 27 | criteria provided, single submitter | clinical testing | The stop gained p.R519* in GRIN2B (NM_000834.5) has been submitted to ClinVar as Pathogenic by multiple submitters but no details are available for independent assesment. It has not been reported in literature in affected individuals. It is novel (not in any individuals) in gnomAD Exomes. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function mutations have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic. | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001252256 | SCV006072977 | pathogenic | Intellectual disability, autosomal dominant 6 | 2025-04-21 | criteria provided, single submitter | clinical testing | Variant summary: GRIN2B c.1555C>T (p.Arg519X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.1555C>T has been observed in the heterozygous state in at least one individual affected with developmental delay, seizures, and abnormal EEG (e.g. Khalaf_2024). The following publication has been ascertained in the context of this evaluation (PMID: 38438125). ClinVar contains an entry for this variant (Variation ID: 391757). Based on the evidence outlined above, the variant was classified as pathogenic. |
Centre de Biologie Pathologie Génétique, |
RCV001252256 | SCV001428008 | pathogenic | Intellectual disability, autosomal dominant 6 | 2019-01-01 | no assertion criteria provided | clinical testing | |
Genome |
RCV001265387 | SCV001443512 | pathogenic | Complex neurodevelopmental disorder | 2018-09-28 | no assertion criteria provided | provider interpretation | Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-09-28 and interpreted as Pathogenic. Variant was initially reported on 2017-01-12 by GTR ID of laboratory name 26957. The reporting laboratory might also submit to ClinVar. |
Genome Diagnostics Laboratory, |
RCV000426345 | SCV001808515 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000426345 | SCV001956675 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |